Purpose: Despite the fact that genetic risk factors contribute to low-grade gliomas (LGGs), the role of critical genes as prognostic and theraputic biomarkers is quite limited. This study is designed to comprehensively investigate the prognostic role and predictive ability of solute carrier family 10 member 3 () for immunotherapy in LGGs.
Methods: We analyzed the prognostic value of from multiple datasets of LGG patients, and explored its immune correlation via multiple algorithms.